Zoon Kathryn C
SEC CIK 1685720 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EBS | Emergent BioSolutions Inc. | Dir | 79.9K | — | $477.9K | 14 | 2022-05-24 | 2026-05-01 |
Most active insiders at EBS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DeGolyer Donald W | Dir | — | $317.6K |
| 2 | Glessner Coleen | EVP, Quality, Ethics, CPL | — | $306.1K |
| 3 | Richard Ronald | Dir | — | $263.1K |
| 4 | Dayal Sujata Tyagi | Dir | — | $201.1K |
| 5 | Zoon Kathryn C | Dir | — | $144.5K |
| 6 | Katkin Keith | Dir | — | $128.2K |
| 7 | Williams Paul Anthony | SVP, Products Business | — | $59.0K |
| 8 | Lowry Simon C | SVP, CMO, R, D | — | — |
| 9 | Perl Jessica | SVP, GC, Corp Sec | — | — |
| 10 | Hartzel William | SVP, Bioservices | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-05-04 17:28 | 2026-04-30 | EBS | Emergent BioSolutions Inc. | Zoon Kathryn C | Dir | A - Grant | $0.00 | +25.3K | 97.1K | +35% | $0 |
| DMT | 2026-05-04 17:28 | 2026-05-01 | EBS | Emergent BioSolutions Inc. | Zoon Kathryn C | Dir | S - Sale | $8.40 | -17.2K | 79.9K | -18% | -$144.5K |
| 2025-08-18 | 2025-08-15 | EBS | Emergent BioSolutions Inc. | Zoon Kathryn C | Dir | S - Sale | $8.87 | -7,086 | 71.8K | -9% | -$62.9K | |
| D | 2025-05-02 | 2025-04-30 | EBS | Emergent BioSolutions Inc. | Zoon Kathryn C | Dir | A - Grant | $0.00 | +34.4K | 78.9K | +77% | $0 |
| 2025-03-12 | 2025-03-12 | EBS | Emergent BioSolutions Inc. | Zoon Kathryn C | Dir | S - Sale | $5.73 | -10.0K | 44.5K | -18% | -$57.3K | |
| 2024-06-06 | 2024-06-04 | EBS | Emergent BioSolutions Inc. | Zoon Kathryn C | Dir | S - Sale | $6.11 | -10.0K | 54.5K | -16% | -$61.1K | |
| 2024-05-31 | 2024-05-29 | EBS | Emergent BioSolutions Inc. | Zoon Kathryn C | Dir | S - Sale | $4.61 | -1,830 | 64.5K | -3% | -$8,436 | |
| D | 2024-05-28 | 2024-05-23 | EBS | Emergent BioSolutions Inc. | Zoon Kathryn C | Dir | A - Grant | $0.00 | +17.4K | 66.3K | +36% | $0 |
| 2024-05-23 | 2024-05-21 | EBS | Emergent BioSolutions Inc. | Zoon Kathryn C | Dir | S - Sale | $5.78 | -1,089 | 48.9K | -2% | -$6,294 | |
| M | 2023-07-24 | 2023-05-25+ | EBS | Emergent BioSolutions Inc. | Zoon Kathryn C | Dir | S - Sale | $8.36 | -3,530 | 50.0K | -7% | -$29.5K |
| 2023-05-30 | 2023-05-25 | EBS | Emergent BioSolutions Inc. | Zoon Kathryn C | Dir | A - Grant | $0.00 | +33.8K | 53.5K | +172% | $0 | |
| 2022-06-13 | 2022-06-09 | EBS | Emergent BioSolutions Inc. | Zoon Kathryn C | Dir | S - Sale | $31.52 | -1,173 | 19.7K | -6% | -$37.0K | |
| 2022-05-31 | 2022-05-26 | EBS | Emergent BioSolutions Inc. | Zoon Kathryn C | Dir | A - Grant | $0.00 | +8,446 | 20.8K | +68% | $0 | |
| 2022-05-25 | 2022-05-24 | EBS | Emergent BioSolutions Inc. | Zoon Kathryn C | Dir | S - Sale | $35.53 | -1,996 | 12.4K | -14% | -$70.9K |
Purchase Sale Sale after option exercise All abbreviations